Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Expands By 6.8%

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 45,500 shares, an increase of 6.8% from the May 31st total of 42,600 shares. Based on an average daily trading volume, of 7,200 shares, the short-interest ratio is presently 6.3 days.

Conduit Pharmaceuticals Stock Performance

Shares of CDTTW traded up $0.01 during midday trading on Tuesday, hitting $0.03. 6,334 shares of the stock traded hands, compared to its average volume of 12,622. Conduit Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.18. The business’s 50 day moving average price is $0.05 and its two-hundred day moving average price is $0.06.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.